Original-Research: Nabaltec AG - von NuWays AG
Einstufung von NuWays AG zu Nabaltec AG
Unternehmen: Nabaltec AG
ISIN: DE000A0KPPR7
Anlass der Studie: Q3 Review
Empfehlung: BUY
seit: 24.11.2023
Kursziel: € 31,00
Kursziel auf Sicht von: 12 Monaten
Letzte Ratingänderung:
Analyst: Christian Sandherr
Q3 review: better-than-feared margin thanks to boehmite; chg
Q3 sales decreased by 12% yoy to € 49.8m (eNuW: € 50.5m) as a result of continued weak end markets, which left a particularly strong mark on the group’s Specialty Alumina segment (-24% yoy to € 14.1m). Positively, demand for its high-margin product boehmite, which has been weak for more than one year, has begun to pick up. This explains the “only” 6% sales decline of the Functional Fillers segment to € 53.7m. In fact, monthly sales volumes should have improved from ~450t to roughly 600t as customers across Eastern Europe are gradually (but slowly) ramping up battery production volumes and Asian customers are slowly reverting back to regular orders.
Q3 EBIT came in better than feared at € 4.6m (eNuW: € 3.4m), a 9.3% margin driven by the improved product mix (higher boehmite and lower Specialty Alumina sales shares) and slightly lower input costs (vs. previous quarters) that compensated for general labour cost inflation.
FY guidance confirmed. At the beginning of August, the company adjusted its FY23 guidance to a 4-6% yoy sales decline (eNuW: 5% with an EBIT margin of 6-8% (eNuW new: 7.8%). While we still expect Nabaltec to meet the mid-point of the sales guidance, the upper end of the EBIT margin guidance should be in reach (9M: 8.4% margin), implying a margin of only 5.8% in Q4.
Balance sheet remains strong. At the end of Q3, Nabaltec’s balance sheet
featured roughly € 15m net cash (€ 93m cash, € 15m short-term financial
assets and € 90m debt). During the next 2-3 years, the company looks set to
invest roughly € 45m into expanding production capacities of boehmite and
APYRAL, a gap filler that is mixed with glues used in battery packs/EVs to
redirect heat away from the
cells. Fully utilized boehmite and APYRAL capacity expansions would yield €
65-70m incremental sales and € 16m EBIT.
What to expect from 2024e. Nabaltec is seen to return to slight growth, thanks to stabilizing sales of core products, environmental friendly flame retardants, and a gradually improving order momentum for boehmite and APYRAL as European EV and battery productions are ramping up. The resulting improvement of the product mix and slight raw material/energy price deflation should allow for further expanding margins. Beyond 2024e, core products should also return to structural growth, in our view.
Nabaltec remains a BUY with an unchanged € 31 PT, based on FCFY 2024e.
Die vollständige Analyse können Sie hier downloaden:
http://www.more-ir.de/d/28395.pdf
Die Analyse oder weiterführende Informationen zu dieser können Sie hier downloaden
www.nuways-ag.com/research.
Kontakt für Rückfragen
NuWays AG - Equity Research
Web: www.nuways-ag.com
Email: research@nuways-ag.com
LinkedIn: https://www.linkedin.com/company/nuwaysag
Adresse: Mittelweg 16-17, 20148 Hamburg, Germany
++++++++++
Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte.
Offenlegung möglicher Interessenskonflikte nach § 85 WpHG beim oben analysierten Unternehmen befinden sich in der vollständigen Analyse.
++++++++++
-------------------übermittelt durch die EQS Group AG.-------------------
Für den Inhalt der Mitteilung bzw. Research ist alleine der Herausgeber bzw. Ersteller der Studie verantwortlich. Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte.
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.